AP2008004394A0 - Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis - Google Patents

Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Info

Publication number: AP2008004394A0
Authority: AP; ARIPO
Prior art keywords: treatment; pharmaceutical composition; composition containing; herpetic keratitis; containing brivudine
Prior art date: 2005-09-29

Application number

AP2008004394A

Other languages

English (en)

Inventor

Reinhard Schmitz

Marc Wihsmann

Original Assignee

Berlin Chemie Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-29

Filing date

2006-09-27

Publication date

2008-04-30

2006-09-27 Application filed by Berlin Chemie Ag filed Critical Berlin Chemie Ag

2008-04-30 Publication of AP2008004394A0 publication Critical patent/AP2008004394A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AP2008004394A 2005-09-29 2006-09-27 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis AP2008004394A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102005046769A DE102005046769A1 (de)	2005-09-29	2005-09-29	Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
PCT/EP2006/009383 WO2007039201A2 (en)	2005-09-29	2006-09-27	Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Publications (1)

Publication Number	Publication Date
AP2008004394A0 true AP2008004394A0 (en)	2008-04-30

Family

ID=37561306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2008004394A AP2008004394A0 (en)	2005-09-29	2006-09-27	Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Country Status (33)

Country	Link
US (1)	US20080249061A1 (no)
EP (1)	EP1940353B1 (no)
JP (1)	JP2009509993A (no)
KR (1)	KR20080053319A (no)
CN (1)	CN101272765A (no)
AP (1)	AP2008004394A0 (no)
AR (1)	AR056551A1 (no)
AT (1)	ATE489076T1 (no)
AU (1)	AU2006299115A1 (no)
BR (1)	BRPI0616449A2 (no)
CA (1)	CA2624111A1 (no)
CR (1)	CR9839A (no)
CY (1)	CY1111059T1 (no)
DE (2)	DE102005046769A1 (no)
DK (1)	DK1940353T3 (no)
EA (1)	EA012975B1 (no)
EC (1)	ECSP088310A (no)
ES (1)	ES2356774T3 (no)
HN (1)	HN2008000497A (no)
HR (1)	HRP20110085T1 (no)
IL (1)	IL190466A0 (no)
MA (1)	MA29887B1 (no)
NO (1)	NO20081488L (no)
PE (1)	PE20070767A1 (no)
PL (1)	PL1940353T3 (no)
PT (1)	PT1940353E (no)
RS (1)	RS51615B (no)
SI (1)	SI1940353T1 (no)
TN (1)	TNSN08094A1 (no)
TW (1)	TW200744664A (no)
UA (1)	UA90911C2 (no)
WO (1)	WO2007039201A2 (no)
ZA (1)	ZA200802729B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009006130A2 (en) *	2007-06-28	2009-01-08	Bausch & Lomb Incorporated	Salt free hyaluronate ophthalmic solution
WO2009100367A2 (en) *	2008-02-06	2009-08-13	Adherex Technologies Inc.	Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
DE102009003942A1 (de) *	2009-01-07	2010-07-08	D2O Biosience Group Ltd., Hamilton	Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
RS58731B1 (sr)	2014-01-22	2019-06-28	Visufarma B V	Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
AU2017261303B9 (en) *	2016-05-06	2021-09-23	Sacsh, Inc.	Ophthalmic compositions
CN113712928A (zh) *	2021-09-29	2021-11-30	重庆市力扬医药开发有限公司	经口腔粘膜吸收的溴夫定药物
EP4623919A1 (en)	2024-03-28	2025-10-01	Marinomed Biotech AG	Composition comprising iota-carrageenan for the treatment of dry eyes, non-viral conjunctivitis and allergic ocular conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY136633A (en) *	2001-01-17	2008-11-28	Berlin Chemie Ag	Stabilized brivudine topical formulations
DE10162593A1 (de) *	2001-12-19	2003-07-03	Menarini Ricerche Spa	Stabilisierte topische Brivudin-Formulierungen

2005
- 2005-09-29 DE DE102005046769A patent/DE102005046769A1/de not_active Withdrawn
2006
- 2006-09-27 EP EP06805904A patent/EP1940353B1/en active Active
- 2006-09-27 US US12/088,397 patent/US20080249061A1/en not_active Abandoned
- 2006-09-27 DK DK06805904.7T patent/DK1940353T3/da active
- 2006-09-27 ZA ZA200802729A patent/ZA200802729B/xx unknown
- 2006-09-27 DE DE602006018505T patent/DE602006018505D1/de active Active
- 2006-09-27 PL PL06805904T patent/PL1940353T3/pl unknown
- 2006-09-27 CN CNA2006800356965A patent/CN101272765A/zh active Pending
- 2006-09-27 AU AU2006299115A patent/AU2006299115A1/en not_active Abandoned
- 2006-09-27 WO PCT/EP2006/009383 patent/WO2007039201A2/en not_active Ceased
- 2006-09-27 TW TW095135667A patent/TW200744664A/zh unknown
- 2006-09-27 AP AP2008004394A patent/AP2008004394A0/xx unknown
- 2006-09-27 RS RS20110016A patent/RS51615B/sr unknown
- 2006-09-27 UA UAA200802782A patent/UA90911C2/ru unknown
- 2006-09-27 AT AT06805904T patent/ATE489076T1/de active
- 2006-09-27 HR HR20110085T patent/HRP20110085T1/hr unknown
- 2006-09-27 EA EA200800646A patent/EA012975B1/ru not_active IP Right Cessation
- 2006-09-27 SI SI200630913T patent/SI1940353T1/sl unknown
- 2006-09-27 ES ES06805904T patent/ES2356774T3/es active Active
- 2006-09-27 BR BRPI0616449-8A patent/BRPI0616449A2/pt not_active IP Right Cessation
- 2006-09-27 JP JP2008532659A patent/JP2009509993A/ja not_active Withdrawn
- 2006-09-27 PT PT06805904T patent/PT1940353E/pt unknown
- 2006-09-27 CA CA002624111A patent/CA2624111A1/en not_active Abandoned
- 2006-09-27 KR KR1020087007483A patent/KR20080053319A/ko not_active Withdrawn
- 2006-09-28 PE PE2006001181A patent/PE20070767A1/es not_active Application Discontinuation
- 2006-09-28 AR ARP060104294A patent/AR056551A1/es unknown
2008
- 2008-02-28 TN TNP2008000094A patent/TNSN08094A1/en unknown
- 2008-03-25 EC EC2008008310A patent/ECSP088310A/es unknown
- 2008-03-26 NO NO20081488A patent/NO20081488L/no not_active Application Discontinuation
- 2008-03-27 CR CR9839A patent/CR9839A/es not_active Application Discontinuation
- 2008-03-27 IL IL190466A patent/IL190466A0/en unknown
- 2008-03-27 HN HN2008000497A patent/HN2008000497A/es unknown
- 2008-04-24 MA MA30877A patent/MA29887B1/fr unknown
2010
- 2010-12-23 CY CY20101101189T patent/CY1111059T1/el unknown

Also Published As

Publication number	Publication date
AU2006299115A1 (en)	2007-04-12
BRPI0616449A2 (pt)	2011-06-21
PL1940353T3 (pl)	2011-05-31
PE20070767A1 (es)	2007-08-13
TW200744664A (en)	2007-12-16
TNSN08094A1 (en)	2009-07-14
CY1111059T1 (el)	2015-06-11
WO2007039201A3 (en)	2007-10-04
MA29887B1 (fr)	2008-10-03
SI1940353T1 (sl)	2011-03-31
JP2009509993A (ja)	2009-03-12
CR9839A (es)	2008-10-31
HRP20110085T1 (hr)	2011-03-31
KR20080053319A (ko)	2008-06-12
UA90911C2 (ru)	2010-06-10
DK1940353T3 (da)	2011-01-24
EP1940353A2 (en)	2008-07-09
ATE489076T1 (de)	2010-12-15
ES2356774T3 (es)	2011-04-13
EA012975B1 (ru)	2010-02-26
CN101272765A (zh)	2008-09-24
PT1940353E (pt)	2011-02-25
AU2006299115A2 (en)	2008-05-29
ZA200802729B (en)	2009-09-30
ECSP088310A (es)	2008-05-30
US20080249061A1 (en)	2008-10-09
AR056551A1 (es)	2007-10-10
EA200800646A1 (ru)	2008-10-30
WO2007039201A2 (en)	2007-04-12
DE602006018505D1 (de)	2011-01-05
HN2008000497A (es)	2010-09-10
NO20081488L (no)	2008-03-26
CA2624111A1 (en)	2007-04-12
RS51615B (sr)	2011-08-31
IL190466A0 (en)	2008-11-03
DE102005046769A1 (de)	2007-04-05
EP1940353B1 (en)	2010-11-24

Publication	Publication Date	Title
IL187999A0 (en)	2008-03-20	Compositions for the treatment of persistent infections
EP1871331A4 (en)	2011-01-05	COMPOSITION FOR THE TREATMENT OF MENOPAUSE
IL191832A0 (en)	2008-12-29	Pyridiazinone derivatives for the treatment of tumours
IL191141A0 (en)	2008-12-29	Heterocyclic compounds and pharmaceutical compositions containing the same
IL186665A0 (en)	2008-01-20	Heterocyclic compounds and pharmaceutical compositions containing the same
IL187434A0 (en)	2008-02-09	Heterocyclic compounds and pharmaceutical compositions containing the same
IL190920A0 (en)	2009-09-22	Compounds for the treatment of metabolic disorders
PL2266961T3 (pl)	2016-04-29	Proces syntezy związków organicznych
IL187748A0 (en)	2008-04-13	Pharmaceutical compositions containing misoprostal
IL190466A0 (en)	2008-11-03	Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
IL185602A0 (en)	2008-08-07	Pharmaceutical compositions containing acarbose
EP1922345A4 (en)	2009-11-11	PROCESS FOR THE PREPARATION OF COPOLYMER-1
EP1871363A4 (en)	2009-01-21	COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
IL186252A0 (en)	2008-08-07	Pharmaceutical compositions containing melatonin derivatives
IL188831A0 (en)	2008-08-07	Compositions for reducing the incidence of drug induced arrhythmia
PL1976522T5 (pl)	2019-12-31	Kompozycja farmaceutyczna zawierająca montelukast
IL187792A0 (en)	2008-11-03	4-anilino-3-quinolinecarbonitriles for the treatment of cancer
ZA200709621B (en)	2008-11-26	Process for the synthesis of organic compounds
IL185076A0 (en)	2007-12-03	Process for the prepartion of enantiomerically pure 1-substituted-3-aminoalcohols
EP1881835A4 (en)	2010-04-07	TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
ZA200805522B (en)	2009-04-29	Dioxoiane dérivates for the treatment of cancer
IL200192A0 (en)	2010-04-15	Composition useful for the treatment of type 2 diabetes
HUP0500685A2 (en)	2007-07-30	Pharmaceutical composition for the treatment of psychosis
HUP0500947A2 (en)	2007-08-28	Composition for treatment of paradontosis
ZA200706203B (en)	2009-12-30	Processes and compounds for the preparation of substituted naphthylindole derivatives